Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neoplasms 12Breast Neoplasms 7Triple Negative Breast Neoplasms 5Ovarian Neoplasms 4Neoplasm Metastasis 4Unspecified Adult Solid Tumor, Protocol Specific 3Sarcoma 3Lymphoma 2Carcinoma, Non-Small-Cell Lung 2Relapsed Solid Tumors 1Refractory Solid Tumors 1Prostatic Neoplasms 1Metastatic Urothelial Cell Cancer 1Melanoma 1Lung Neoplasms 1Liposarcoma 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Advanced Solid Tumors 1

Interventions

Doxorubicin 4ribociclib 2belinostat 2Radiotherapy 2siremadlin 1selinexor 1sargramostim 1romidepsin 1peposertib 1pembrolizumab 1liposomal doxorubicin 1ixazomib 1eribulin 1cixutumumab 1avelumab 1Trabectedin 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Magnetic Resonance Spectroscopy 1Ifosfamide 1Histamine H2 Antagonists 1Gemcitabine 1Fulvestrant 1Fluorouracil 1Famotidine 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Celecoxib 1Biopsy 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Liposarcoma × eribulin × Clear all
NCT03361436 2026-04-08

Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery

OHSU Knight Cancer Institute

Phase 1 Active not recruiting
15 enrolled
Sarcoma

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡